PRESS RELEASE
Aug 14, 2025
BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results
Aug 14, 2025
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
Jul 30, 2025
BioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025
Jul 17, 2025
BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes
Jul 10, 2025
BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET
Jun 23, 2025
BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers
Jun 17, 2025
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
Jun 08, 2025
BioStem Technologies: Huge Growth, Poised To Help Wound Care Field
Jun 03, 2025
BioStem Technologies Provides Update on the Company's Form 10 Submission and SEC Review Process
May 29, 2025
BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference